EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA
Publication
, Conference
Keir, S; Reardon, D; Friedman, H; Bigner, D
Published in: NEURO-ONCOLOGY
May 1, 2011
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
May 1, 2011
Volume
13
Start / End Page
I7 / I7
Location
New Orleans, LA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keir, S., Reardon, D., Friedman, H., & Bigner, D. (2011). EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA. In NEURO-ONCOLOGY (Vol. 13, pp. I7–I7). New Orleans, LA: OXFORD UNIV PRESS INC.
Keir, Stephen, David Reardon, Henry Friedman, and Darell Bigner. “EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA.” In NEURO-ONCOLOGY, 13:I7–I7. OXFORD UNIV PRESS INC, 2011.
Keir S, Reardon D, Friedman H, Bigner D. EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011. p. I7–I7.
Keir, Stephen, et al. “EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA.” NEURO-ONCOLOGY, vol. 13, OXFORD UNIV PRESS INC, 2011, pp. I7–I7.
Keir S, Reardon D, Friedman H, Bigner D. EFFICACY OF AP24534 (PONATINIB) +/- BEVACIZUMAB AGAINST PEDIATRIC GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011. p. I7–I7.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
May 1, 2011
Volume
13
Start / End Page
I7 / I7
Location
New Orleans, LA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences